Pura Vida Investments, LLC Gilead Sciences, Inc. Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $3.21 Million - $3.51 Million	-50,602 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $3.04 Million - $3.46 Million	50,602 New	50,602 $3.27 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $3.62 Million - $4.2 Million	-50,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $3.13 Million - $4.01 Million	50,000 New	50,000 $3.74 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $9.24 Million - $10.2 Million	-150,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $3.13 Million - $3.45 Million	50,000 Added 50.0%	150,000 $9.51 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $6.25 Million - $7.01 Million	100,000 New	100,000 $6.5 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.